Overview

Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial

Status:
Recruiting

Trial end date:
2021-02-01

Target enrollment:

Participant gender:

Summary

This study aims to assess the efficacy and safety of using combination of 755-nm picosecond alexandrite laser and 2% hydroquinone compared with 2% hydroquinone alone for the treatment of melasma: A randomized split-face controlled trial

Phase:

N/A

Details

Lead Sponsor:

Mahidol University

Treatments:

Hydroquinone